- $5.14bn
- $8.89bn
- $1.24bn
- 56
- 62
- 80
- 72
2019 December 31st | C2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 650 | 691 | 806 | 1,351 | 1,351 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 648 | 691 | 668 | 1,344 | 1,271 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 300 | 288 | 225 | 577 | -0.91 |
Provision for Income Taxes | |||||
Net Income After Taxes | 234 | 228 | 179 | 447 | 3.68 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 234 | 228 | 195 | 463 | 542 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 234 | 219 | 186 | 454 | 533 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.41 | 2.84 | 1.66 | 2.59 | -0.013 |
Dividends per Share | |||||
Special Dividends per Share |